Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clopidogrel variability: role of plasma protein binding alterations.

British journal of clinical pharmacology - 1 Jun 2013

Ganesan Shobana, Williams Craig, Maslen Cheryl L, Cherala Ganesh

Abstract excerpt

AIM: The large inter-individual variability in clopidogrel response is attributed to pharmacokinetics. Although, it has been used since the late 1990s the pharmacokinetic fate of clopidogrel and its metabolites are poorly explained. The variable response to clopidogrel is believed to be multi-factorial, caused both by genetic and non-genetic factors. In this study, we examined whether the inactive metabolite can...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Proteins
Share to Chromatography, Liquid
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Platelet Aggregation

Share to Platelet Aggregation Inhibitors

Share to Platelet Function Tests

Share to Statistics as Topic

Share to Ticlopidine

Source

Open in PubMed Open full text

Identifiers

PMID: 23116430
DOI: 10.1111/bcp.12017
PMCID: PMC3690105

Genes

VASP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Clopidogrel variability: role of plasma protein binding alterations.PMID 23116430Read ↗

Impact of selected genetic factors on clopidogrel inactive metabolite level and antiplatelet response in patients after percutaneous coronary intervention.Semantic proximity Read ↗

Impact of common ABCB1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites.Semantic proximity Read ↗

Relationship between pharmacokinetics and pharmacodynamics of clopidogrel in patients undergoing percutaneous coronary intervention: comparison between vasodilator-stimulated phosphoprotein phosphorylation assay and multiple electrode aggregometry.Semantic proximity Read ↗

Mechanisms of variability in antiplatelet agents response.Semantic proximity Read ↗

Impact of P-glycoprotein on clopidogrel absorption.Semantic proximity Read ↗

Randomized double-blind placebo-controlled crossover study to determine the effects of esomeprazole on inhibition of platelet function by clopidogrel.Semantic proximity Read ↗

The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts.Semantic proximity Read ↗

Clopidogrel pharmacodynamics and pharmacokinetics in the fed and fasted state: a randomized crossover study of healthy men.Semantic proximity Read ↗

Individual variations of platelet inhibition after loading doses of clopidogrel.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.